SEPTEMBER 11, 2023Dianthus Therapeutics, Inc. /DE/ • September 12th, 2023 • Pharmaceutical preparations
Company FiledSeptember 12th, 2023 IndustryBy way of this letter, your Severance Letter Agreement dated April 3, 2023 (the “Severance Letter”) by and between you and Dianthus Therapeutics OpCo, Inc. (f/k/a Dianthus Therapeutics, Inc.) (the “Company”) is hereby terminated, and Section 5 of your Offer Letter dated January 20, 2022 (the “Offer Letter”) by and between you and the Company is hereby amended to and restated in its entirety to read as follows:
SEPTEMBER 11, 2023Dianthus Therapeutics, Inc. /DE/ • September 12th, 2023 • Pharmaceutical preparations
Company FiledSeptember 12th, 2023 IndustryBy way of this letter, Section 5 of your Offer Letter dated October 31, 2021 (the “Offer Letter”) by and between you and Dianthus Therapeutics OpCo, Inc. (f/k/a Dianthus Therapeutics, Inc.) (the “Company”) is hereby amended to and restated in its entirety to read as follows:
SEPTEMBER 11, 2023Dianthus Therapeutics, Inc. /DE/ • September 12th, 2023 • Pharmaceutical preparations
Company FiledSeptember 12th, 2023 IndustryBy way of this letter, Section 5 of your Offer Letter dated January 18, 2022 (the “Offer Letter”) by and between you and Dianthus Therapeutics OpCo, Inc. (f/k/a Dianthus Therapeutics, Inc.) (the “Company”) is hereby amended to and restated in its entirety to read as follows: